Alder Biopharmaceuticals

ALDR

10.65

+0.20

+1.9%

Please Login or Register

Login|Register FREE

Stock Price
Open: 10.40
Prev. Close: 10.45
Low/Hi: 10.34 - 10.75
52-Week: 8.60 - 35.62
Volumes
Equity: 270,014
90-Day Avg: 1,632,100
Option: 11
90-Day Avg: 655
Volatility
Todays Stock Vol: 37.5
20-Day (HV): 57.3
52-Week (HV): 68.0
30-Day IV: 57.0 -0.8
IV Pct Rank: 40% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 3-Nov (Est.)
P/E Ratio:
Market Cap: 707.6 M
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ALDR Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 127,789 79,713 116,216 170,632
Short Term Investments 96,692 209,851 235,651 232,757
Investments - - - -
Accounts Receivable 0 0 0 0
Inventory 936 936 936 936
Loans - - - -
Prepaid Expenses 21,221 19,827 40,380 23,682
Net Property Plant and Equipment 6,714 6,776 7,076 6,610
Other Current Assets 0 0 0 0
Current Assets 246,638 310,327 393,183 428,007
Goodwill and Intangibles 0 0 0 0
Long Term Investments 586 716 865 956
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 253,968 317,849 409,154 443,603
Short Term Debt 0 0 0 0
Other Non-Current Assets 30 30 8,030 8,030
Accounts Payable 19,796 20,300 10,361 5,703
Accrued Liabilities and Other Payables 14,236 9,243 15,437 10,952
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 34,547 30,090 26,371 16,867
Other Current Liabilities 92 92 92 96
Accumulated Other Comprehensive Income -68 5 -48 60
Preferred Stock 0 0 0 0
Current Liabilities 34,124 29,635 25,890 16,751
Common Stock 5 5 5 5
Other Non-Current Liabilities 423 455 481 116
Additional Paid-In Capital 773,071 766,707 761,456 756,410
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -553,587 -478,958 -378,630 -329,739
Total Equity 219,421 287,759 382,783 426,736
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Cash and Cash Equivalents 116,216 206,492 46,795
Short Term Investments 235,651 98,680 9,077
Investments - - -
Accounts Receivable 0 0 113
Inventory 936 0 0
Loans - - -
Prepaid Expenses 40,380 17,029 4,758
Net Property Plant and Equipment 7,076 1,974 1,160
Other Current Assets 0 0 0
Current Assets 393,183 322,201 60,743
Goodwill and Intangibles 0 0 0
Long Term Investments 865 75,840 0
Other Assets - - -
Long Term Receivables 0 0 0
Total Assets 409,154 400,027 64,359
Short Term Debt 0 0 0
Other Non-Current Assets 8,030 12 2,456
Accounts Payable 10,361 4,727 1,911
Accrued Liabilities and Other Payables 15,437 7,583 2,963
Long Term Debt 0 0 0
Other Liabilities - - -
Current Portion of Long Term Debt 0 0 0
Total Liabilities 26,371 12,510 5,202
Other Current Liabilities 92 62 135
Accumulated Other Comprehensive Income -48 -501 -22
Preferred Stock 0 0 0
Current Liabilities 25,890 12,372 5,009
Common Stock 5 4 3
Other Non-Current Liabilities 481 138 193
Additional Paid-In Capital 761,456 610,390 196,082
Treasury Stock 0 0 0
Other Equity 0 0 0
Retained Earnings -378,630 -222,376 -136,906
Total Equity 382,783 387,517 59,157